SNSE — Sensei Biotherapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $16.78m
- -$39.86m
- 35
- 53
- 49
- 42
Annual cashflow statement for Sensei Biotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -16.7 | -20.1 | -36.8 | -48.6 | -34.1 |
| Depreciation | |||||
| Non-Cash Items | 4.63 | 2.58 | 5.73 | 7.21 | 5.06 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.47 | -0.397 | 0.117 | 1.01 | -4.33 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -8.57 | -17.7 | -30.3 | -39 | -32 |
| Capital Expenditures | -0.053 | -1.21 | -2.03 | -0.321 | -0.18 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -0.197 | -141 | 50.3 | 38.6 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.053 | -1.4 | -143 | 49.9 | 38.4 |
| Financing Cash Flow Items | — | -2.1 | 0.08 | 0.104 | -0.028 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 8.22 | 35.5 | 164 | -0.287 | -11.2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.402 | 16.3 | -9.44 | 10.6 | -4.78 |